Articles On Polynovo (ASX:PNV)

The S&P/ASX 200 Index (ASX: XJO) stock Scentre Group (ASX: SCG) has been hurting a lot. Since the start of 2023, the Scentre share price has fallen 14%. It's down 20% from 24 January 2023 and it's down around 40% from mid-January 2020....

Investing, like most other activities in life, requires practice and experience for any human to become competent at it. In fact, some people may never even reach competency even after years of training. So when those who have done it succ...

With apologies to Charles Dickens, it’s the best of times and the worst of times for wound care house Next Science (ASX:NXS) as it shapes itself up for a renewed market assault under a new CEO. On the positive side of the ledger, the compan...

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

The S&P/ASX 200 Index (ASX: XJO) is down 0.28% to 7,018.5 points in afternoon trade following a slump on Wall Street last night. Part of the burdensome weight on the share market's shoulders is the rising yield on bonds. Overnight, th...

Pro Medicus Limited (ASX: PME) shares were on fire on Tuesday despite the market weakness. The health imaging technology company's shares stormed 12% higher to a record high. Investors were scrambling to get hold of its shares after it an...

It was back to old, bad habits for the S&P/ASX 200 Index (ASX: XJO) during Tuesday's trading session. After the ASX 200 snapped its five-day losing streak yesterday with a tentative gain...

The S&P/ASX 200 Index (ASX: XJO) is out of form on Tuesday. In afternoon trade, the benchmark index is down 0.5% to 7,043.1 points. Four ASX shares that are not letting that hold them back are listed below. Here's why they are pushing...

It hasn't been a great day for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares so far this Tuesday. At the time of writing, the ASX 200 has slipped by 0.71%. But that hasn't stopped one ASX exchange-traded fund (ETF) from hitting...

Another day, another set of 52-week highs for ASX uranium shares! Most uranium miners are rising on Tuesday, in contrast to the rest of the market. The S&P/ASX 200 Energy Index (ASX: XEJ) started the day higher but is now down 0.19%...

It's been a pretty awful start to this Tuesday's trading for the S&P/ASX 300 Index (ASX: XKO) and ASX 300 shares so far today. At present, the ASX 300 has slipped by 0.32% and is back to around 7,000 points. So given this slip for the...

Australian medical device company PolyNovo (ASX:PNV) has announced that it more than doubled its revenue in August compared to the same month last year.

Another 4% fall in the price of iron ore was almost enough to drive the S&P/ASX200 (INDEXASX: XJO) lower, with the materials sector falling 0.7% to open the week. Both BHP Group Ltd (ASX: BHP) and Rio Tinto Ltd (ASX: RIO) fell by more t...

The S&P/ASX 200 Index (ASX: XJO) has delighted investors hoping for a reprieve from the share market today with a green session. After falling every single trading day last week, the ASX...

The S&P/ASX 200 Index (ASX: XJO) is out of form on Monday. In afternoon trade, the benchmark index is down 0.2% to 7,057 points. Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:...

It's completely normal to worry about stock market risk and investing in ASX shares if you're a beginner investor just starting out (or wanting to) on your investing journey. Entrusting your cash to the whims of the markets is no easy feat...

Polynovo Ltd (ASX: PNV) shares have return from a short trading halt with a bang. In early afternoon trade, the medical device company's shares are up 12% to $1.37. Why are Polynovo shares racing higher? Investors have been fighting to get...

The TechnologyOne Ltd (ASX: TNE) share price is starting the week strongly. At the time of writing, the ASX 200 tech share is up 2.5% to $15.65. This compares favourably to the performance of the ASX 200 index, which is down 0.35%. Why is...

Chances are you've heard the phrase 'safe as houses' when discussing investing options for Australian investors. I'd be equally certain thought that the phrase 'safe as ASX shares' is one that most people haven't heard. The general consens...

It's been a happy end to the trading week indeed for the S&P/ASX 200 Index (ASX: XJO) and ASX shares this Friday. After having a fairly bumpy week, the ASX 200 went out in style today, recordi...

Polynovo Ltd (ASX: PNV) shares have struggled to find support in 2023. After a brief reprieve between May and August, the wound treatment company has seen its share price slapped with a 22.3% decline over the last 29 days. On Friday, shar...

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

The Monadelphous Group Ltd (ASX: MND) share price is lifting on Wednesday morning. In early trade, the ASX 200 engineering company's shares are up 1% to $14.16. Why is this ASX 200 share rising? Investors have been buying Monadelphous shar...

The Liontown Resources Ltd (ASX: LTR) share price is rising on Wednesday. In morning trade, the lithium developer's shares are up 1% to $3.03. Why is the Liontown share price rising? This morning, Liontown revealed that it is business as u...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to start the week with a gain. At the time of writing, the benchmark index is up a fraction to 7,159.7 points. Four ASX shares that have failed to follow the marke...

The S&P/ASX 200 Index (ASX: XJO) has finished the trading week on another low note this Friday. After falling every day since Tuesday, the ASX 200 saw no reason to change course this session. By cl...

ASX health sector fall in line with broader markets as macroeconomic factors create uncertainty Clinuvel down as its European label expansion of SCENESSE knocked back pending further data 2023 biotech market darling elevated to the S&P...

It has been another busy week for Australia's top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these...

The S&P/ASX 200 Index (ASX: XJO) looks set to continue its losing streak on Friday. In afternoon trade, the benchmark index is down 0.4% to 7,142.6 points. Four ASX shares that are not letting that hold them back are listed below. He...

SunCable is now moving forward under new ownership, with a renewed focus on the plan to link Australian renewable power with Asian demand, thanks to an impressive power cable. SunCable will still get its time in the sun. For readers that h...

S&P/ASX 200 Index (ASX: XJO) shares closed the session on Wednesday down 0.78% to 7,257.1 points. With the official reporting season now over, we look at 10 ASX 200 shares that brokers say are a buy following their earnings updates. 10...

Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a number of broker notes this week. Three ASX shares brokers have named as buys this week are listed below. Here’s why the...

S&P/ASX 200 Index (ASX: XJO) shares are trading lower on Wednesday, down 0.28% to 7,293 points. Meantime, these two companies have received broker upgrades, as reported in The Australian today. Let’s take a look. Polynovo shares a bu...

In this week's Weekly Insights:-Outlook Negative, With Plenty Of Silver Linings-Conviction Calls & Best IdeasBy Rudi Filapek-Vandyck, EditorOne of the stand-out features of the August results season has been the resilience of household ...

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

S&P/ASX 300 Index (ASX: XKO) shares finished the session on Friday down 0.9% to 7,073.4 points. As earnings season continues, more ASX 300 shares traversed the charts this week on the back of their company earnings reports. As is cus...

Local shares rallied on Wednesday Results from Wisetech, Domino’s and Woolworths were highlights Global funds ditched Chinese stocks, says Bloomberg   The ASX rallied around half a percentage point on Wednesday, boosted by earnings result...

Local shares were up modestly on Tuesday A hectic day in earnings again, with tech stock Altium leading the way Data#3 was the worst-performing large cap   The ASX 200 traded flattish by +0.04% on Tuesday after another hectic day of earni...

Local shares down another -0.7pc today Core Lithium fell over 20pc on cap raise news The AUD pummelled to below US64c   The ASX 200 has extended yesterday’s 1.5% loss by another 0.5% on Thursday, weighed by Healthcare,Tech and Mining sect...

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

It ended up being a horrid hump day for the S&P/ASX 200 Index (ASX: XJO) this Wednesday. After recording a positive day yesterday, the sellers returned in force this session. By the end of trading, the ASX 200 ha...

ASX down around 1.5pc on China’s troubles All sectors were down, led by Tech and Mining The AUD is at lowest level in nine months on commodity demand concerns   The ASX 200 sank nearly 1.5% today as soft earnings by real estate majors com...

The S&P/ASX 200 Index (ASX: XJO) finally recorded a win for investors today after two days of consecutive falls over Friday and Monday. As of close of trading this Tuesday, the ASX 200 had finished up at 7,305 poi...

ASX pushed higher after earnings reports by majors Cochlear, CSL, and Seek reported results today In a surprising move, China’s central bank PBOC cuts its key lending rates   The ASX 200 gained around 0.3% on Tuesday after a slew of earni...

The S&P/ASX 200 Index (ASX: XJO) has given investors a disappointing end to the trading week this Friday. By market close, the ASX 200 had slipped by 0.24%, dragging the index down to 7,340.1 points. That was after...

Local shares dropped on Friday, but up slightly for the week Energy stocks weighed after a 2pc drop in crude prices Microsoft to become a subject of US government investigation over breach   The ASX 200 dropped by -0.25% on Friday, and fo...

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

There’s nothing better than buying a couple of S&P/ASX 200 Index (ASX: XJO) shares nice and early on their upward curve. You may have bought later than the bottom, but that’s a small premium to pay for reduced risk that the business w...

It was a bit of a disappointing false start for the S&P/ASX 200 Index (ASX: XJO) and ASX shares this Monday. After initially rising enthusiastically this morning, the ASX 200 seemed to get a bad case of cold feet over this a...